Coloplast A/S (OTCMKTS:CLPBY) Sees Large Increase in Short Interest

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 80,200 shares, an increase of 27.7% from the October 15th total of 62,800 shares. Based on an average daily volume of 120,000 shares, the days-to-cover ratio is currently 0.7 days.

Coloplast A/S Stock Down 0.8 %

CLPBY opened at $12.78 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.56 and a debt-to-equity ratio of 1.00. Coloplast A/S has a one year low of $10.61 and a one year high of $14.34. The business’s fifty day moving average is $13.12 and its two-hundred day moving average is $12.85.

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.08 EPS for the quarter. The firm had revenue of $1.02 billion for the quarter. Coloplast A/S had a net margin of 18.69% and a return on equity of 31.17%. As a group, equities analysts forecast that Coloplast A/S will post 0.38 EPS for the current fiscal year.

Coloplast A/S Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, December 20th. Investors of record on Monday, December 9th will be paid a $0.2435 dividend. The ex-dividend date is Monday, December 9th. This is a positive change from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s dividend payout ratio is presently 27.27%.

About Coloplast A/S

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

See Also

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.